Brind.

Zacks Investment Research published stock analysis reports concerning Guardant Health on July 31, 2025.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Guardant Health

Keep exploring

The entities involved

Guardant Health
American biotechnology company
- Scott Bessent's call for a rate cut fuels a risk-on environment for companies like agilon health.Sun 05:03
- EVANS welcomed Guardant Health as a sponsor for a coalition planning events across North America.Sat 21:20

Coverage

Newest first; wire copies grouped

Jul 31ZacksGuardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates For the quarter ended June 2025, Guardant Health (GH) reported revenue of $232.09 million, up 31% over the same period